Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions.

Publication Year: 2022

DOI:
10.1111/bcp.15435

PMCID:
PMC9795926

PMID:
35675118

Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"COMPETING INTERESTS R.O.D., M.J.C., K.T., M.K., E.A., A.R. and S.L.S. declare no conflicts of interest. P.C. is founder and Chief Executive of Prospection Pty Ltd, the software used in the analyses in this work. M.K. and V.C. are employees of Prospection Pty Ltd. P.C., M.K. and V.C. acknowledge receipt of fees paid to Prospection Pty Ltd from R.O.D.'s Lexy Davies Bequest funding to update Prospection's PharmDash platform with relevant PBS data for the purposes of the study."

Evidence found in paper:

"Funding information Lexy Davies Bequest at St Vincent's Hospital, Sydney"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025